NCT01855633Recruiting
Repetitive Transcranial Magnetic Stimulation in Patients With Hemiplegic Stroke
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Brief summary (registry, in English)
Stroke is one of the major causes of death in the World. Many stroke survivors may suffer from long-term sequelae of stroke such as hemiplegia. The effects of rehabilitation therapy are limited. The development of new treatment strategies is essential. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive method to stimulate the focal area of the brain for restoring brain function. The aim of this study is to investigate the therapeutic effect of rTMS on the motor recovery in patients with hemiplegic stroke.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- First submitted
- 10 May 2013
- Start date
- 26 Apr 2013
- Primary completion date
- Dec 2039
- Lead sponsor
- Dongtan Sacred Heart Hospital
- Diseases
- Stroke
- NCT number
- NCT01855633
What you commit to
- Study type: Interventional
- Planned participants: 48
- From 26 Apr 2013 to the primary completion date, Dec 2039
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of previous symptomatic stroke
- Persons with surgically or traumatically implanted foreign bodies such as a pacemaker, an implanted medication pump, a metal plate in the skull, or metal inside the skull or eyes (other than dental appliances or fillings), intracardiac lines that may pose a physical hazard during magnetic stimulation will also be excluded
Other illness
- Patients with history of seizure disorder or epilepsy
Other
- pregnant women
- Subjects without the capacity to give informed consent
Who the study is looking for
- stroke patients with motor weakness
- Medical research council (MRC) grade 0-4
- More than 2 weeks after stroke onset
- Age 18 years and older
- Able to provide consent for the protocol
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dongtan Sacred Heart Hospital Coordinator of this site? Confirm its status | Hwaseong-si | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.